TNF Pharmaceuticals, Inc.
The momentum for this stock is not very good. TNF Pharmaceuticals, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in TNF Pharmaceuticals, Inc. .
Log in to see more information.
News
TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline
Business Wire TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (TNFA or the Company), a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases, and autoimmune and...\n more…
TNFA Stock Earnings: TNF Pharmaceuticals Reported Results for Q2 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nTNF Pharmaceuticals just reported results for the second quarter of 2024.\nThe post TNFA Stock Earnings: TNF Pharmaceuticals Reported...\n more…